• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于多种互补和正交色谱及检测方法的分析策略(多检测器方法),以有效管理分析评估阈值(AET)。

An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET).

作者信息

Jordi Mark, Heise Ted

机构信息

Jordi Labs, Mansfield, MA; and

MED Institute Inc., West Lafayette, IN.

出版信息

PDA J Pharm Sci Technol. 2021 May-Jun;75(3):289-301. doi: 10.5731/pdajpst.2020.012047. Epub 2020 Nov 16.

DOI:10.5731/pdajpst.2020.012047
PMID:33199517
Abstract

To address patient safety, a drug product is chromatographically screened for organic leachables. Similarly, medical device and packaging system extracts are chromatographically screened for organic extractables as probable leachables. To protect patient health, the screening methods must respond to all potentially unsafe substances. To be efficient, analytes determined to be below the toxicologically relevant threshold are removed from consideration before the subsequent analytical tasks of identification and quantitation are performed. The analytical evaluation threshold (AET) was established for use as a toxicologically relevant threshold to differentiate between chromatographic peaks that are unlikely to be unsafe (and thus do not need safety assessment) and those that are possibly unsafe (and thus require safety assessment). In practice, the instrumental response associated with the AET is determined using surrogate standards. It is then assumed that the response strength for an unknown extractable is equivalent to that for the surrogate standard at the AET concentration (i.e., relative response factor = 1). It is an unfortunate reality that response factors vary for different compounds on nearly all detector systems. This complicates the application of the AET and can result in a failure to include potentially toxicologically relevant compounds in the identification phase of the analysis. To ensure protection, an uncertainty factor was built into the AET equation that adjusts the AET downward to address response variation. Although this mechanism does increase the protectiveness of the AET, it assumes that the available methodology and instrumentation is sufficiently sensitive to reach the new lowered AET value. However, in some cases, the response variation is so great and the resulting uncertainty factor so large that the revised AET is below the achievable sensitivity specifications of even state-of-the art, expertly operated instrumental technologies. The only option then remaining is to concentrate the samples, which can result in adverse effects on analysis quality-counteracting the perceived benefit of lowering the AET. This article demonstrates how an analytical strategy based on methods with multiple complementary and orthogonal detection techniques (a multidetector approach) mitigates the problem of response factor variation and thus eliminates the need for large uncertainty factors and the resulting lower AET values. The primary concept is that all analytes only need to be effectively detected by at least one of the combination of detectors applied, and it is this effective technique (combination of all detectors and chromatographic methods utilized) that is used to perform the AET assessment.

摘要

为确保患者安全,需对药品进行有机可溶出物的色谱筛选。同样,需对医疗设备和包装系统提取物进行有机可提取物的色谱筛选,以确定可能的可溶出物。为保护患者健康,筛选方法必须能检测出所有潜在的不安全物质。为提高效率,在进行后续的鉴定和定量分析任务之前,需将测定结果低于毒理学相关阈值的分析物排除在考虑范围之外。设立分析评估阈值(AET)作为毒理学相关阈值,以区分不太可能不安全的色谱峰(因此无需进行安全性评估)和可能不安全的色谱峰(因此需要进行安全性评估)。在实际操作中,使用替代标准物确定与AET相关的仪器响应。然后假设在AET浓度下未知可提取物的响应强度与替代标准物的响应强度相当(即相对响应因子 = 1)。不幸的是,几乎所有检测系统中不同化合物的响应因子都有所不同。这使得AET的应用变得复杂,并可能导致在分析的鉴定阶段未能纳入潜在的毒理学相关化合物。为确保防护,在AET方程中纳入一个不确定因子来向下调整AET,以应对响应变化。尽管这种机制确实提高了AET 的防护性,但它假定现有的方法和仪器足够灵敏,能够达到新降低后的AET值。然而,在某些情况下,响应变化非常大且由此产生的不确定因子也非常大,以至于修订后的AET甚至低于最先进的、操作熟练的仪器技术所能达到的灵敏度规格要求。那么剩下的唯一选择就是对样品进行浓缩,但这可能会对分析质量产生不利影响,抵消降低AET所带来的预期益处。本文展示了基于多种互补和正交检测技术的分析策略(多检测器方法)如何减轻响应因子变化的问题,从而消除对大的不确定因子以及由此产生较低AET值的需求。主要理念是所有分析物只需通过所应用的检测器组合中的至少一种得到有效检测,正是这种有效技术(所使用的所有检测器和色谱方法的组合)用于进行AET评估。

相似文献

1
An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET).一种基于多种互补和正交色谱及检测方法的分析策略(多检测器方法),以有效管理分析评估阈值(AET)。
PDA J Pharm Sci Technol. 2021 May-Jun;75(3):289-301. doi: 10.5731/pdajpst.2020.012047. Epub 2020 Nov 16.
2
The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation.对色谱筛选医疗产品中的有机可浸出物进行分析评估时,需将响应因子变化引起的分析评估检测限调整至检测下限以下。
PDA J Pharm Sci Technol. 2021 May-Jun;75(3):273-288. doi: 10.5731/pdajpst.2020.012013. Epub 2020 Nov 16.
3
Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.采用多检测器方法减少提取和浸出物(E&L)分析中的相对响应因子变化,以减少不确定性因素的需要。
J Pharm Biomed Anal. 2020 Jul 15;186:113334. doi: 10.1016/j.jpba.2020.113334. Epub 2020 May 1.
4
A Practical Derivation of the Uncertainty Factor Applied to Adjust the Extractables/Leachables Analytical Evaluation Threshold (AET) for Response Factor Variation.应用不确定度因子对提取/浸出物分析评估阈值(AET)进行调整以应对响应因子变化的实用推导。
PDA J Pharm Sci Technol. 2022 May-Jun;76(3):178-199. doi: 10.5731/pdajpst.2021.012692. Epub 2021 Nov 15.
5
Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.校正分析评估阈值 (AET) 和报告的可提取物浓度,以解决与色谱筛选提取物/浸出物相关的分析响应因子不确定性。
PDA J Pharm Sci Technol. 2020 May-Jun;74(3):348-358. doi: 10.5731/pdajpst.2019.010520. Epub 2020 Apr 15.
6
Identification and quantification of medical device extractables and leachables via non-target analysis (NTA); Analytical uncertainty.通过非靶向分析(NTA)鉴定和量化医疗器械浸出物和可提取物;分析不确定度。
J Pharm Biomed Anal. 2024 Apr 15;241:115985. doi: 10.1016/j.jpba.2024.115985. Epub 2024 Jan 19.
7
Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.通过管理结果实现有机可提取物和可沥滤物色谱筛选方法的标准化。
PDA J Pharm Sci Technol. 2023 Jul-Aug;77(4):329-338. doi: 10.5731/pdajpst.2021.012671. Epub 2023 Mar 31.
8
A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.一份与药品包装、给药、管理及生产系统中所用材料相关的可提取物安全性影响信息汇编。
PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):407-55. doi: 10.5731/pdajpst.2014.00995.
9
Qualitative assessment of extractables from single-use components and the impact of reference standard selection.一次性使用组件浸出物的定性评估及参比标准选择的影响
J Pharm Biomed Anal. 2018 Feb 20;150:368-376. doi: 10.1016/j.jpba.2017.12.029. Epub 2017 Dec 19.
10
Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.识别和减轻有机浸出物和可提取物筛选中的错误:第 1 部分-色谱筛选有机浸出物和可提取物中的错误简介以及对遗漏错误的讨论。
PDA J Pharm Sci Technol. 2020 Jan-Feb;74(1):90-107. doi: 10.5731/pdajpst.2018.009761. Epub 2019 Jun 17.

引用本文的文献

1
Uncertainty factors and relative response factors: correcting detection and quantitation bias in extractables and leachables studies.不确定因素和相对响应因子:校正可提取物和可浸出物研究中的检测和定量偏差。
Anal Bioanal Chem. 2025 Jul 15. doi: 10.1007/s00216-025-05946-5.